Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.

Jude, Edward B; Nixon, Mark; O'Leary, Caroline; Myland, Melissa; Gooch, Nick; Shaunik, Alka; Lew, Elisheva

Jude, Edward B; Nixon, Mark; O'Leary, Caroline; Myland, Melissa; Gooch, Nick; Shaunik, Alka; Lew, Elisheva.

Afiliación

Jude EB; Diabetes Centre, Tameside General Hospital, Ashton-under-Lyne, UK. Edward.Jude@tgh.nhs.uk.
Nixon M; University of Manchester, Manchester, UK. Edward.Jude@tgh.nhs.uk.
O'Leary C; IQVIA, London, UK.
Myland M; IQVIA, London, UK.
Gooch N; IQVIA, London, UK.
Shaunik A; Sanofi, Guildford, UK.
Lew E; Sanofi, Bridgewater, NJ, USA.

Diabetes Ther ; 10(5): 1847-1858, 2019 Oct.

Article en En | MEDLINE | ID: mdl-31321748

Palabras clave

Basal insulin; Glycemic control; Therapy intensification; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google